The cost-effectiveness of introducing a varicella vaccine to the New Zealand immunisation schedule
- 1 July 1999
- journal article
- Published by Elsevier in Social Science & Medicine
- Vol. 49 (6) , 763-779
- https://doi.org/10.1016/s0277-9536(99)00115-x
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- A Practical Guide for Calculating Indirect Costs of DiseasePharmacoEconomics, 1996
- Costs And Benefits Of Routine Varicella Vaccination In German ChildrenThe Journal of Infectious Diseases, 1996
- THE EPIDEMIOLOGY OF VARICELLA-ZOSTER VIRUS INFECTIONSInfectious Disease Clinics of North America, 1996
- The friction cost method for measuring indirect costs of diseaseJournal of Health Economics, 1995
- Time Preference in Medical EconomicsMedical Decision Making, 1994
- Epidemiologic effects of vaccines with complex direct effects in an age-structured populationMathematical Biosciences, 1994
- Cost-effectiveness of a routine varicella vaccination program for US childrenPublished by American Medical Association (AMA) ,1994
- On what basis should health be discounted?Journal of Health Economics, 1993
- Oka/Merck varicella vaccine in healthy children: final report of a 2-year efficacy study and 7-year follow-up studiesVaccine, 1991
- Foundations of Cost-Effectiveness Analysis for Health and Medical PracticesNew England Journal of Medicine, 1977